Caplin Point Laboratories Competitors and Similar CompaniesClear all
Caplin Point Laboratories's competitors and similar companies include Alembic Pharmaceuticals, UCB, Cipla and EMS Pharma.
 Caplin Point Laboratories Caplin Point Laboratories is a pharmaceutical company manufacturing a range of formulations. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | |
Founding Date | Founding Date 1990 | Founding Date 2010 | Founding Date 1928 | Founding Date 1935 | Founding Date 1964 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Chennai, IN HQ Chennai, IN Gerugambakkam, IN Suthukeny, IN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations BR HQ |
Employees | Employees 3,406 | Employees 14,858 | Employees 9,052 | Employees 27,764 | Employees 12,7441% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹21.9b (FY, 2026) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹8.7b (FY, 2026) | Cost of goods ₹19.8b (FY, 2026) | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit ₹14.4b (FY, 2026) | Gross profit ₹54.1b (FY, 2026) | Gross profit €7.2b (FY, 2025) | Gross profit ₹195b (FY, 2026) | Gross profit N/A |
Net income | Net income ₹6.5b (FY, 2026) | Net income ₹6.7b (FY, 2026) | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income N/A |
Operating ⚠ | |||||
Products | Products N/A | Products 145 (FY, 2024) | Products N/A | Products 1.5 k (FY, 2024) | Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company